The Role of Fibroblast Growth Factor Signalling in Osteosarcoma  by Mahalingam, S. et al.
ABSTRACTS
Contents lists available at ScienceDirect
International Journal of Surgery
journal homepage: www.thei js .com
Abstracts / International Journal of Surgery 9 (2011) 363–369 365ADMINISTRATION OF BONE MARROW STROMAL CELLS FACILITATE
AXONAL REGENERATION IN THE HEMISECTED ADULT RAT SPINAL CORD
K. Bhatt 1, M. Enomoto 2, T. Hirai 2, K. Shinomiya 2. 1 Imperial College
London, UK; 2 Tokyo Medical and Dental University, Tokyo
Background: Spinal Cord Injury causes a huge burden for patients, with
a lack of effective surgical treatment & continuous cost of care. Bone
Marrow Stromal Cells (BMSC) and artiﬁcial extracellular matrices have
been shown to aid recovery in various models. We proposed the combined
use of BMSCs with a Honeycomb Collagen (HC) matrix to aid axonal
regeneration.
Materials & Methods: In-vitro study of explanted rat Dorsal Root Ganglia
onto BMSC infused HC scaffolds compared against the HC control were
evaluated. Maximum neurite length after 10 days was calculated. The
study continued to an in-vivo study of spinal cord hemisection in rat
models, with the injury site being surgically implanted with HC or
BMSC+HC scaffolds. 4 weeks post injury the cords were evaluated for
injury site volume compared to total cord volume. Basso Beattie Bresnahan
score and sub score was used to analyse motor recovery.
Results: Explants showed a signiﬁcant difference in neurite length, with
BMSC + HC group producing 3x greater growth (p value 0.0004). The SCI
Injury model showed a tendency of BMSC+HC to have a smaller injury site
volume. Motor recovery was signiﬁcantly higher in the BMSC+HC group in
both the BBB score and BBB subscore (p ¼ 0.03 & p ¼ 0.005 respectively).
Conclusion: Wesuccessfully showed thatBMSCshaveefﬁcacycompared to
HC controls in both in-vitro and in-vivo axonal regeneration, with a func-
tional recovery being greater in the BMSC group. Therefore both structural
and cellular support is needed for a surgical intervention to aid recovery.THE ROLE OF FIBROBLAST GROWTH FACTOR SIGNALLING IN
OSTEOSARCOMA
S. Mahalingam, R. Al-Dabbagh, D. Weekes, A.E Grigoriadis. King’s College
London
Background: The mechanisms responsible for the development of oste-
osarcomas are unknown. Preliminary experiments using a mousemodel of
osteosarcoma (OS) suggest a role for ﬁbroblast growth factor (FGF) sig-
nalling in oncogenic transformation of osteoblasts. We hypothesise
a similar case in humans. We investigated the role of ﬁbroblast growth
factors and receptors (FGFRs) in the growth of human osteoblasts. Our
aims: to compare FGFR expression between normal human osteoblasts
(HOBs) and OS cells; compare effects of FGF on growth of HOBs and OS
cells; and establish a 3-dimensional culture model representing an in vivo
environment.
Methodology: Western blot analysis of FGFR expression was performed
on HOBs and 3 human OS cell lines (MG-63, Saos2, U2OS). Using cell
culture techniques, we investigated the effect of bFGF and SU5402 (FGFR
inhibitor) on cell transformation and proliferation. In parallel to these in
vitro experiments, we developed an in ovo model. Our system involves
grafting tumours (explants frommouse model) onto chick chorioallantoic-
membrane (CAM).
Results: FGFR1 and FGFR4 were overexpressed in OS cell lines compared
to HOBS. bFGF induced features of transformed cells in HOBs; this was
reversed by SU5402. bFGF increased proliferation of OS cells in comparison10.1016/j.ijsu.2011.03.004to HOBs. All tumours grafted onto the CAM, especially those treated with
bFGF, became vascularised.
Conclusion: This new evidence suggests a vital role for FGF signalling in
the pathogenesis of OS. Furthermore, the ﬁrst steps have been taken in
developing an in ovo tumour culture system. This can be developed to
study the effects of modulating exogenous factors on tumour growth.ARTERIAL FUNCTION IN PATIENTS WITH DIABETES MELLITUS
UNDERGOING CORONARY ARTERY BYPASS GRAFTING
Temitope Bademosi, T.A. Barker, M. Iafrancesco. Warwick University
Objectives: Type-2 diabetes mellitus is a risk factor for morbidity/
mortality following coronary artery bypass grafting (CABG), which may be
attributable in part to arterial stiffening. We aimed to identify if patients
with increased arterial stiffness pre-operatively had worse outcomes
following CABG, whilst also investigating the potential molecular deter-
minants of arterial stiffening within aortic biopsies.
Methods: Measurements of arterial stiffness, Pulse Wave Velocity, on 12
non-diabetics and 17 Type-2 diabetics were correlated with indirect
predictors of poor outcome followingCABG (peakpost-operative troponinT,
day 4 creatinine).Aortic biopsies were analysed by zymography for levels of
the extracellularmatrix enzymeMMP-2. Data are represented asmeans and
percentages. Results were assessed using appropriate statistical tests and
correlation coefﬁcients were calculated. P<0.05 was considered signiﬁcant.
Results: PWVwassigniﬁcantly increased indiabetics,13.92 (11.78-16.46)m/
s vs. non-diabetics 9.34 (8.70- 10.02) m/s, (p<0.001). In diabetics only,PWV
was signiﬁcantly and positively correlated with peak troponin T (rho¼0.65,
pvalue¼0.03) and day 4 creatinine (rho¼0.64, p value¼0.02). Analyses of the
aortic tissue indicated an increase in percentage MMP- 2 activity (50% vs.
30%) in diabetics vs. non-diabetics (not statistically signiﬁcant).
Conclusions: PWV may be a useful tool for predicting a group of diabetic
patients that have worse outcomes following CABG. Interventions to
reduce arterial stiffness in the future could be focused on this high-risk
subpopulation. A therapeutic target may include modulation of MMP-2
activity, a possible pathophysiology of aortic stiffening.THE EFFECT OF AORTIC GRAFTS ON TONOMETRIC MEASUREMENT OF
ARTERIAL COMPLIANCE
Adam Mulla 2, Thomas A. Barker 1,2, Robert S. Bonser 1,2, Mauro
Iafrancesco 1, Peter Nightingale 1, Malcolm H. Simms 1, John Townend 1,2,
Domenico Pagano 1,2. 1 University Hospital Birmingham NHS Foundation
Trust; 2 University of Birmingham
Objectives: The aorta buffers pulsatile cardiac output into peripheral non-
pulsatile ﬂow. Tonometric measurements of arterial compliance can
predict future cardiovascular events, but the segment of aorta responsible
for the pathophysiological effects of arterial stiffening is unknown. We
investigated this in patients with differing anatomical aortic segment
prosthetic replacements.
Methods: We measured tonometric carotid-femoral Pulse Wave Velocity
(PWV) using a Sphygmocor device in 4 patient groups: CONTROL subjects
with low cardiovascular risk; THORACIC patients with aortic root grafts;
ABDOMINAL patients with operated infra-renal aortic aneurysms;
